The effectiveness of
lixisenatide as
an
add on
therapy to
basal insulin in
diabetic type
2 patients previously treated with
different
insulin regimes: a multi
-center observational
study
Božek, T., Bilić Ćurčić, I., Cigrovski Berković, M., Gradišer, M., Tićinović Kurir, T., Klobučar Majanović, S. i Marušić, S. (2018). The effectiveness of
lixisenatide as
an
add on
therapy to
basal insulin in
diabetic type
2 patients previously treated with
different
insulin regimes: a multi
-center observational
study. Diabetology and Metabolic Syndrome, 10.. doi: 10.1186/s13098-018-0321-x
Božek, Tomislav, et al. "The effectiveness of
lixisenatide as
an
add on
therapy to
basal insulin in
diabetic type
2 patients previously treated with
different
insulin regimes: a multi
-center observational
study." Diabetology and Metabolic Syndrome, vol. 10, 2018. https://doi.org/10.1186/s13098-018-0321-x
Božek, Tomislav, Ines Bilić Ćurčić, Maja Cigrovski Berković, Marina Gradišer, Tina Tićinović Kurir, Sanja Klobučar Majanović i Srećko Marušić. "The effectiveness of
lixisenatide as
an
add on
therapy to
basal insulin in
diabetic type
2 patients previously treated with
different
insulin regimes: a multi
-center observational
study." Diabetology and Metabolic Syndrome 10 (2018). https://doi.org/10.1186/s13098-018-0321-x
Božek, T., et al. (2018) 'The effectiveness of
lixisenatide as
an
add on
therapy to
basal insulin in
diabetic type
2 patients previously treated with
different
insulin regimes: a multi
-center observational
study', Diabetology and Metabolic Syndrome, 10. doi: 10.1186/s13098-018-0321-x
Božek T, Bilić Ćurčić I, Cigrovski Berković M, Gradišer M, Tićinović Kurir T, Klobučar Majanović S, i sur.. The effectiveness of
lixisenatide as
an
add on
therapy to
basal insulin in
diabetic type
2 patients previously treated with
different
insulin regimes: a multi
-center observational
study. Diabetology and Metabolic Syndrome [Internet]. 13.03.2018. [pristupljeno 20.08.2024.];10. doi: 10.1186/s13098-018-0321-x
T. Božek, et al., "The effectiveness of
lixisenatide as
an
add on
therapy to
basal insulin in
diabetic type
2 patients previously treated with
different
insulin regimes: a multi
-center observational
study", Diabetology and Metabolic Syndrome, vol. 10, Ožujak 2018. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:184:714639. [Citirano: 20.08.2024.]